KBTBD13
gene geneOn this page
Also known as hCG_1645727NEM6
Summary
KBTBD13 (kelch repeat and BTB domain containing 13, HGNC:37227) is a protein-coding gene on chromosome 15q22.31, encoding Kelch repeat and BTB domain-containing protein 13 (C9JR72). Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex.
The gene belongs to a family of genes encoding proteins containing a BTB domain and several kelch repeats. The BTB domain functions as a protein-protein interaction module, which includes an ability to self-associate or to interact with non-BTB domain-containing proteins. The kelch motif typically occurs in groups of five to seven repeats, and has been found in proteins with diverse functions. Known functions of these family members include transcription regulation, ion channel tetramerization and gating, protein ubiquitination or degradation, and cytoskeleton regulation. The exact function of this family member has yet to be determined.
Source: NCBI Gene 390594 — RefSeq curated summary.
At a glance
- Gene–disease (curated): nemaline myopathy 6 (Definitive, ClinGen) — +2 more curated relationships
- Clinical variants (ClinVar): 741 total — 1 pathogenic, 2 likely-pathogenic
- Phenotypes (HPO): 55
- MANE Select transcript:
NM_001101362
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37227 |
| Approved symbol | KBTBD13 |
| Name | kelch repeat and BTB domain containing 13 |
| Location | 15q22.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | hCG_1645727, NEM6 |
| Ensembl gene | ENSG00000234438 |
| Ensembl biotype | protein_coding |
| OMIM | 613727 |
| Entrez | 390594 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000432196
RefSeq mRNA: 1 — MANE Select: NM_001101362
NM_001101362
CCDS: CCDS45281
Canonical transcript exons
ENST00000432196 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001724191 | 65076746 | 65079948 |
Expression profiles
Bgee: expression breadth broad, 47 present calls, max score 86.19.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0312 / max 10.8695, expressed in 19 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 147219 | 0.0312 | 19 |
Top tissues by expression
120 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.19 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 83.10 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 81.93 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.12 | silver quality |
| apex of heart | UBERON:0002098 | 76.88 | gold quality |
| muscle of leg | UBERON:0001383 | 74.06 | gold quality |
| gastrocnemius | UBERON:0001388 | 72.81 | gold quality |
| heart left ventricle | UBERON:0002084 | 71.05 | gold quality |
| muscle tissue | UBERON:0002385 | 69.65 | gold quality |
| popliteal artery | UBERON:0002250 | 66.62 | gold quality |
| tibial artery | UBERON:0007610 | 66.60 | gold quality |
| heart | UBERON:0000948 | 66.22 | gold quality |
| right atrium auricular region | UBERON:0006631 | 65.77 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 60.86 | gold quality |
| thoracic aorta | UBERON:0001515 | 53.54 | gold quality |
| ascending aorta | UBERON:0001496 | 52.92 | gold quality |
| left uterine tube | UBERON:0001303 | 49.27 | gold quality |
| sural nerve | UBERON:0015488 | 47.76 | gold quality |
| left coronary artery | UBERON:0001626 | 44.35 | gold quality |
| fallopian tube | UBERON:0003889 | 44.20 | gold quality |
| endocervix | UBERON:0000458 | 43.25 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 43.24 | silver quality |
| body of uterus | UBERON:0009853 | 42.87 | gold quality |
| uterine cervix | UBERON:0000002 | 42.41 | gold quality |
| urinary bladder | UBERON:0001255 | 42.00 | silver quality |
| bone marrow cell | CL:0002092 | 41.88 | gold quality |
| right coronary artery | UBERON:0001625 | 41.82 | gold quality |
| ectocervix | UBERON:0012249 | 41.81 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 41.48 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.13 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.98 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
70 targeting KBTBD13, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-23B-5P | 99.98 | 66.07 | 587 |
| HSA-MIR-6793-5P | 99.97 | 65.95 | 758 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-23A-5P | 99.94 | 65.39 | 468 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-383-3P | 99.85 | 65.84 | 1359 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-204-5P | 99.79 | 71.62 | 2439 |
| HSA-MIR-211-5P | 99.79 | 71.65 | 2440 |
| HSA-MIR-3934-3P | 99.76 | 65.51 | 1351 |
| HSA-MIR-11181-3P | 99.75 | 66.38 | 2205 |
| HSA-MIR-1827 | 99.63 | 68.57 | 3265 |
| HSA-MIR-516B-5P | 99.56 | 66.33 | 1495 |
| HSA-MIR-18A-3P | 99.56 | 65.68 | 1092 |
| HSA-MIR-4441 | 99.49 | 66.56 | 3216 |
| HSA-MIR-3692-5P | 99.29 | 67.04 | 1421 |
| HSA-MIR-4667-3P | 99.26 | 65.45 | 1608 |
| HSA-MIR-6744-3P | 99.22 | 64.41 | 972 |
| HSA-MIR-4291 | 99.20 | 68.88 | 2969 |
| HSA-MIR-6852-5P | 99.17 | 66.69 | 2073 |
| HSA-MIR-4757-5P | 99.12 | 64.51 | 981 |
| HSA-MIR-6814-5P | 99.03 | 66.68 | 1273 |
Literature-anchored findings (GeneRIF, showing 5)
- mutation screening led to the identification of a previously uncharacterized gene, KBTBD13, coding for a hypothetical protein and containing missense mutations that perfectly cosegregate with nemaline myopathy in the studied families (PMID:21109227)
- these results demonstrate that KBTBD13 is a putative substrate adaptor for Cul3-RL that functions as a muscle specific ubiquitin ligase, and thereby implicate the ubiquitin proteasome pathway in the pathogenesis of KBTBD13-associated NEM. (PMID:22542517)
- KBTBD13 is an actin-binding protein that modulates muscle kinetics. (PMID:31671076)
- NEM6, KBTBD13-Related Congenital Myopathy: Myopathological Analysis in 18 Dutch Patients Reveals Ring Rods Fibers, Cores, Nuclear Clumps, and Granulo-Filamentous Protein Material. (PMID:33693846)
- KBTBD13 is a novel cardiomyopathy gene. (PMID:36335629)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | kbtbd13a | ENSDARG00000076449 |
| mus_musculus | Kbtbd13 | ENSMUSG00000054978 |
Paralogs (54): KLHL13 (ENSG00000003096), KLHL20 (ENSG00000076321), KEAP1 (ENSG00000079999), KLHL42 (ENSG00000087448), KLHL22 (ENSG00000099910), KLHL4 (ENSG00000102271), KLHL2 (ENSG00000109466), KLHL5 (ENSG00000109790), BACH2 (ENSG00000112182), KLHL18 (ENSG00000114648), KLHL24 (ENSG00000114796), IVNS1ABP (ENSG00000116679), KLHL12 (ENSG00000117153), KLHL29 (ENSG00000119771), KBTBD7 (ENSG00000120696), KLHL7 (ENSG00000122550), KLHL31 (ENSG00000124743), KLHDC7B (ENSG00000130487), KLHL36 (ENSG00000135686), KLHL8 (ENSG00000145332), KLHL3 (ENSG00000146021), KLHL35 (ENSG00000149243), KLHL1 (ENSG00000150361), BACH1 (ENSG00000156273), KLHL40 (ENSG00000157119), KLHL10 (ENSG00000161594), KLHL21 (ENSG00000162413), KLHDC8A (ENSG00000162873), KBTBD8 (ENSG00000163376), KBTBD6 (ENSG00000165572), KLHL26 (ENSG00000167487), KLHL30 (ENSG00000168427), KBTBD2 (ENSG00000170852), KLHL6 (ENSG00000172578), KLHL15 (ENSG00000174010), KLHL38 (ENSG00000175946), KBTBD11 (ENSG00000176595), KLHDC7A (ENSG00000179023), KLHL28 (ENSG00000179454), KBTBD3 (ENSG00000182359)
Protein
Protein identifiers
Kelch repeat and BTB domain-containing protein 13 — C9JR72 (reviewed: C9JR72)
All UniProt accessions (1): C9JR72
UniProt curated annotations — full annotation on UniProt →
Function. Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex.
Subunit / interactions. Component of the BCR(KBTBD13) E3 ubiquitin ligase complex, at least composed of CUL3 and KBTBD13 and RBX1. Interacts with CUL3.
Subcellular location. Cytoplasm.
Tissue specificity. Expressed in skeletal muscle.
Post-translational modifications. Autoubiquitinated.
Disease relevance. Nemaline myopathy 6 (NEM6) [MIM:609273] A form of nemaline myopathy characterized by childhood onset of slowly progressive proximal muscle weakness, exercise intolerance, and slow movements with stiff muscles. Patients are unable to run or correct themselves from falling over. The disease is caused by variants affecting the gene represented in this entry.
Domain organisation. The BCB domain mediates the interaction with CUL3.
Pathway. Protein modification; protein ubiquitination.
RefSeq proteins (1): NP_001094832* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR006652 | Kelch_1 | Repeat |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR015915 | Kelch-typ_b-propeller | Homologous_superfamily |
| IPR052392 | Kelch-BTB_domain-containing | Family |
Pfam: PF00651, PF01344
UniProt features (10 total): repeat 5, sequence variant 3, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-C9JR72-F1 | 90.56 | 0.76 |
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-8951664 | Neddylation |
| R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation |
| R-HSA-1280218 | Adaptive Immune System |
| R-HSA-168256 | Immune System |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-597592 | Post-translational protein modification |
| R-HSA-983169 | Class I MHC mediated antigen processing & presentation |
MSigDB gene sets: 187 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_DN, REACTOME_ADAPTIVE_IMMUNE_SYSTEM, REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION, REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_MULTICELLULAR_ORGANISMAL_MOVEMENT, GOBP_SKELETAL_MUSCLE_CONTRACTION, GOBP_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION, GOBP_REGULATION_OF_MUSCLE_CONTRACTION, GOBP_MUSCLE_CONTRACTION, GOBP_ACTIN_FILAMENT_ORGANIZATION, GOBP_RELAXATION_OF_MUSCLE, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, GOBP_REGULATION_OF_SYSTEM_PROCESS, GOMF_ACTIN_BINDING
GO Biological Process (4): actin filament organization (GO:0007015), regulation of the force of skeletal muscle contraction (GO:0014728), protein ubiquitination (GO:0016567), relaxation of skeletal muscle (GO:0090076)
GO Molecular Function (2): actin filament binding (GO:0051015), protein binding (GO:0005515)
GO Cellular Component (2): cytosol (GO:0005829), cytoplasm (GO:0005737)
Reactome top-level categories
Rollup of top-5 pathways:
| Category | Pathways |
|---|---|
| Post-translational protein modification | 1 |
| Class I MHC mediated antigen processing & presentation | 1 |
| Immune System | 1 |
| Metabolism of proteins | 1 |
| Adaptive Immune System | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| actin cytoskeleton organization | 1 |
| supramolecular fiber organization | 1 |
| regulation of skeletal muscle contraction by chemo-mechanical energy conversion | 1 |
| protein modification by small protein conjugation | 1 |
| relaxation of muscle | 1 |
| actin binding | 1 |
| protein-containing complex binding | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
598 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KBTBD13 | TNNT1 | P13805 | 932 |
| KBTBD13 | TPM2 | P06468 | 897 |
| KBTBD13 | TPM3 | P06753 | 884 |
| KBTBD13 | KLHL40 | Q2TBA0 | 878 |
| KBTBD13 | NEB | P20929 | 862 |
| KBTBD13 | ACTA1 | P02568 | 857 |
| KBTBD13 | CFL2 | Q9Y281 | 822 |
| KBTBD13 | LMOD3 | Q0VAK6 | 799 |
| KBTBD13 | CUL3 | Q13618 | 725 |
| KBTBD13 | MYPN | Q86TC9 | 658 |
| KBTBD13 | CCDC78 | A2IDD5 | 620 |
| KBTBD13 | MYOT | Q9UBF9 | 615 |
| KBTBD13 | MYO18B | Q8IUG5 | 598 |
| KBTBD13 | RYR1 | P21817 | 561 |
| KBTBD13 | KLHDC1 | Q8N7A1 | 531 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KBTBD13 | CUL3 | psi-mi:“MI:0915”(physical association) | 0.730 |
| CUL3 | KBTBD13 | psi-mi:“MI:0407”(direct interaction) | 0.730 |
| KBTBD13 | CUL3 | psi-mi:“MI:0407”(direct interaction) | 0.730 |
BioGRID (2): KBTBD13 (Proximity Label-MS), CUL3 (Affinity Capture-Western)
ESM2 similar proteins: A6NE02, A8MY62, C9JR72, D3Z7H8, D3ZU57, O09017, O15197, O19179, O95382, P0C0K6, P10588, P43136, P55203, Q02846, Q08DG4, Q15628, Q2KHV9, Q3U0S6, Q3UH93, Q5BK61, Q5U651, Q5W7P8, Q5ZMM1, Q6ZNJ1, Q6ZQA0, Q6ZVZ8, Q80ZD5, Q86WK7, Q8BH02, Q8BH83, Q8C828, Q8CIG9, Q8IUL8, Q8IYS2, Q8JGM4, Q8K2J9, Q8N239, Q8VHA6, Q91X21, Q96CD0
Diamond homologs: A0A1B8YAB1, A1YPR0, B0WWP2, B1H285, B3M9V8, B3NDN0, B4GRJ2, B4HIK1, B4J045, B4L0G9, B4LIG6, B4MXW3, B4PD06, B4QLQ2, C9JR72, D3Z8N4, E0CZ16, G3X9X1, O15062, O88939, O93567, O95365, P28575, P41182, P41183, Q08CL3, Q08DK3, Q13105, Q16RL8, Q2M0J9, Q3UQV5, Q52KB5, Q5EXX3, Q5R7B8, Q5RDY3, Q5TC79, Q5ZI33, Q5ZKD9, Q5ZM39, Q60821
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
741 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 2 |
| Uncertain significance | 464 |
| Likely benign | 159 |
| Benign | 35 |
Top pathogenic / likely-pathogenic (3)
| Variant ID | HGVS | Classification |
|---|---|---|
| 31062 | NM_001101362.3(KBTBD13):c.1222C>T (p.Arg408Cys) | Pathogenic |
| 1709118 | NM_001101362.3(KBTBD13):c.1170G>T (p.Lys390Asn) | Likely pathogenic |
| 31061 | NM_001101362.3(KBTBD13):c.1170G>C (p.Lys390Asn) | Likely pathogenic |
SpliceAI
50 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:65077777:TG:T | donor_gain | 0.5500 |
| 15:65077778:GG:G | donor_gain | 0.5500 |
| 15:65077838:C:G | donor_gain | 0.5400 |
| 15:65077487:G:GA | donor_gain | 0.4600 |
| 15:65077987:G:T | donor_gain | 0.4500 |
| 15:65077788:G:GG | donor_gain | 0.4300 |
| 15:65077787:A:AG | donor_gain | 0.4200 |
| 15:65077486:T:TA | donor_gain | 0.3900 |
| 15:65077986:G:GT | donor_gain | 0.3800 |
| 15:65077622:G:GT | donor_gain | 0.3700 |
| 15:65077774:TGGTG:T | donor_gain | 0.3300 |
| 15:65077775:GGTGG:G | donor_gain | 0.3300 |
| 15:65077778:G:GT | donor_gain | 0.3300 |
| 15:65077781:G:GG | donor_gain | 0.3300 |
| 15:65077879:T:A | donor_gain | 0.3300 |
| 15:65077884:C:A | donor_gain | 0.3300 |
| 15:65077482:G:GT | donor_gain | 0.3200 |
| 15:65077780:A:AG | donor_gain | 0.3200 |
| 15:65077886:C:T | donor_gain | 0.3200 |
| 15:65078006:G:GA | donor_gain | 0.3200 |
| 15:65077783:ACGC:A | donor_gain | 0.3100 |
| 15:65078017:A:AG | donor_gain | 0.3100 |
| 15:65077856:G:GA | donor_gain | 0.3000 |
| 15:65077821:C:G | donor_gain | 0.2900 |
| 15:65077880:G:GA | donor_gain | 0.2900 |
| 15:65078005:T:A | donor_gain | 0.2900 |
| 15:65078033:C:A | donor_gain | 0.2900 |
| 15:65077362:G:GT | donor_gain | 0.2700 |
| 15:65077488:G:GG | donor_gain | 0.2700 |
| 15:65077749:T:TA | acceptor_gain | 0.2700 |
AlphaMissense
2920 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:65077374:T:A | W187R | 0.992 |
| 15:65077374:T:C | W187R | 0.992 |
| 15:65077376:G:C | W187C | 0.992 |
| 15:65077376:G:T | W187C | 0.992 |
| 15:65077889:C:A | N358K | 0.992 |
| 15:65077889:C:G | N358K | 0.992 |
| 15:65078023:T:A | V403D | 0.992 |
| 15:65077905:T:C | F364L | 0.991 |
| 15:65077907:C:A | F364L | 0.991 |
| 15:65077907:C:G | F364L | 0.991 |
| 15:65077950:T:A | W379R | 0.989 |
| 15:65077950:T:C | W379R | 0.989 |
| 15:65077449:T:G | Y212D | 0.988 |
| 15:65077875:T:G | Y354D | 0.988 |
| 15:65077291:C:A | A159D | 0.987 |
| 15:65077670:G:C | W285C | 0.987 |
| 15:65077670:G:T | W285C | 0.987 |
| 15:65077906:T:G | F364C | 0.987 |
| 15:65078076:T:A | W421R | 0.987 |
| 15:65078076:T:C | W421R | 0.987 |
| 15:65077453:T:A | I213N | 0.986 |
| 15:65077979:C:A | N388K | 0.986 |
| 15:65077979:C:G | N388K | 0.986 |
| 15:65077836:A:C | S341R | 0.985 |
| 15:65077838:C:A | S341R | 0.985 |
| 15:65077838:C:G | S341R | 0.985 |
| 15:65077885:G:C | R357P | 0.984 |
| 15:65077888:A:T | N358I | 0.984 |
| 15:65078103:T:C | F430L | 0.984 |
| 15:65078105:C:A | F430L | 0.984 |
dbSNP variants (sampled 300 via entrez): RS1000048869 (15:65075077 A>G,T), RS1000651112 (15:65075998 T>C), RS1000804949 (15:65080386 G>A), RS1001021711 (15:65075813 C>T), RS1002052042 (15:65076785 C>G,T), RS1002328838 (15:65075056 T>A), RS1002591118 (15:65075876 C>G,T), RS1002641714 (15:65077707 G>A,C), RS1002787310 (15:65079726 G>A), RS1002818615 (15:65079907 G>A), RS1003439253 (15:65074847 G>A), RS1003614549 (15:65078401 G>C), RS1004050576 (15:65078698 G>A), RS1004504480 (15:65077772 C>G,T), RS1004602137 (15:65077065 T>A,C)
Disease associations
OMIM: gene MIM:613727 | disease phenotypes: MIM:609273, MIM:161800, MIM:615083
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| nemaline myopathy 6 | Definitive | Autosomal dominant |
| childhood-onset nemaline myopathy | Supportive | Autosomal dominant |
| hereditary peripheral neuropathy | Limited | Autosomal recessive |
ClinGen Gene-Disease Validity (1)
Expert-panel classifications — Definitive > Strong > Moderate > Limited > Disputed > Refuted.
| Disease | Classification | Inheritance |
|---|---|---|
| nemaline myopathy 6 | Definitive | AD |
Mondo (5): nemaline myopathy 6 (MONDO:0012237), congenital myopathy 2a, typical, autosomal dominant (MONDO:0008070), colorectal cancer, susceptibility to, 12 (MONDO:0014038), childhood-onset nemaline myopathy (MONDO:0015738), hereditary peripheral neuropathy (MONDO:0020127)
Orphanet (3): Childhood-onset nemaline myopathy (Orphanet:171439), Congenital myopathy with excess of thin filaments (Orphanet:98904), Attenuated familial adenomatous polyposis (Orphanet:220460)
HPO phenotypes
55 total (30 of 55 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000006 | Autosomal dominant inheritance |
| HP:0000218 | High palate |
| HP:0000275 | Narrow face |
| HP:0000276 | Long face |
| HP:0000316 | Hypertelorism |
| HP:0000347 | Micrognathia |
| HP:0000467 | Neck muscle weakness |
| HP:0000508 | Ptosis |
| HP:0000774 | Narrow chest |
| HP:0001265 | Hyporeflexia |
| HP:0001270 | Motor delay |
| HP:0001284 | Areflexia |
| HP:0001288 | Gait disturbance |
| HP:0001290 | Generalized hypotonia |
| HP:0001349 | Facial diplegia |
| HP:0001371 | Flexion contracture |
| HP:0001533 | Slender build |
| HP:0001561 | Polyhydramnios |
| HP:0001623 | Breech presentation |
| HP:0001638 | Cardiomyopathy |
| HP:0001761 | Pes cavus |
| HP:0001989 | Fetal akinesia sequence |
| HP:0002067 | Bradykinesia |
| HP:0002068 | Neuromuscular dysphagia |
| HP:0002312 | Clumsiness |
| HP:0002483 | Bulbar signs |
| HP:0002515 | Waddling gait |
| HP:0002650 | Scoliosis |
| HP:0002747 | Respiratory insufficiency due to muscle weakness |
| HP:0002792 | Reduced vital capacity |
GWAS associations
0 associations (top):
MeSH disease descriptors (3)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C579880 | Actin-Accumulation Myopathy (supp.) | |
| C580202 | Intranuclear Rod Myopathy (supp.) | |
| C538398 | Nemaline myopathy 6 (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression | 1 |
| abrine | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation, increases methylation | 1 |
| Cadmium | increases expression | 1 |
| Thiram | increases expression | 1 |
| Triclosan | decreases expression | 1 |
Clinical trials (associated diseases)
2 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT03211923 | Not specified | UNKNOWN | Muscle Relaxation in Myopathies With Positive Muscle Phenomena |
| NCT03278093 | Not specified | UNKNOWN | Effect of Orthoses and Underfoot Vibration on Balance in Neuropathy |
Related Atlas pages
- Associated diseases: nemaline myopathy 6, childhood-onset nemaline myopathy, hereditary peripheral neuropathy
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): childhood-onset nemaline myopathy, colorectal cancer, susceptibility to, 12, congenital myopathy 2a, typical, autosomal dominant, hereditary peripheral neuropathy, nemaline myopathy 6